Price Chart

Profile

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 360,000 insulin-dependent diabetics are using it worldwide.
URL https://www.insulet.com
Investor Relations URL https://investor.insulet.com
HQ State/Province Massachusetts
Sector Healthcare
Industry Medical Devices
Equity Style Mid Cap/Growth
Next Earnings Release May. 03, 2024 (est.)
Last Earnings Release Feb. 22, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 360,000 insulin-dependent diabetics are using it worldwide.
URL https://www.insulet.com
Investor Relations URL https://investor.insulet.com
HQ State/Province Massachusetts
Sector Healthcare
Industry Medical Devices
Equity Style Mid Cap/Growth
Next Earnings Release May. 03, 2024 (est.)
Last Earnings Release Feb. 22, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A